Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever Anti-CD20 Antibody Conjugated Allogenic Gamma Delta T Cell Therapy for Non-Hodgkins Lymphoma
Trane Technologies plc (TT)
Company Research
Source: PR Newswire
First dosing dohort was completed with complete response and disease stabilization identified at three months at the lowest dose level in the Phase 1 studyNo ACE1831-related serious adverse events, including GvHD, neurotoxicity, high-grade CRS or dose limiting toxicities were observedResults shared during a fireside chat hosted by William Blair & Company on May 7th, 2024. An archived recording will be available for 7 days following the event at https://www.acepodia.com/newsroom/media/. ALAMEDA, Calif. and TAIPEI, May 8, 2024 /PRNewswire/ -- Acepodia (6976:TT), a clinical stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) and allogeneic gamma delta 2 (?d2) T cell platforms to address gaps in cancer care, today announced preliminary data from its Phase 1 dose escalation clinical trial of ACE1831, an anti-CD20 antibody conjugated allogeneic gamma delta T cell therapy being evaluated in patients with non-Hodgkin's lymphoma
Show less
Read more
Impact Snapshot
Event Time:
TT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TT alerts
High impacting Trane Technologies plc news events
Weekly update
A roundup of the hottest topics
TT
News
- Mitsubishi Electric Trane HVAC US Celebrates Distributors' Achievements at 2023 Diamond Leadership Awards Ceremony [Yahoo! Finance]Yahoo! Finance
- Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]Yahoo! Finance
- Trane Technologies Accelerates Growth through Leading Sustainability Performance [Yahoo! Finance]Yahoo! Finance
- Trane Technologies Accelerates Growth through Leading Sustainability PerformanceBusiness Wire
- Range Energy and Thermo King Collaborate to Advance the Commercial Adoption of Electric Refrigerated Trailers in the AmericasBusiness Wire
TT
Earnings
- 4/30/24 - Beat
TT
Sec Filings
- 4/30/24 - Form S-3ASR
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- TT's page on the SEC website